Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03982979 · ClinicalTrials.gov registry record
MOMENTUM 3 Pivotal Cohort Extended Follow-up PAS
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 295
- Enrollment target
NCT03982979 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 295 participants.
The verdict
NCT03982979 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 295 participants
- Enrollment target
Study Summary
The study will be a prospective, multi-center, non-blinded, controlled study, intended to evaluate the extended use of the HM3 LVAS compared to the HMII LVAS in those patients that are ongoing at the 2-year follow-up in the MOMENTUM 3 IDE trial. A total of 1028 subjects were enrolled in the MOMENTUM 3 IDE trial. Approximately 533 subjects were ongoing support at the 2-year follow-up and are eligible for enrollment in this PAS. This study will be conducted at sites that participated in the MOMENTUM 3 IDE trial which will include up to 69 centers in the United States.
Interventions
- DEVICE HM3 LVAS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 295 participants |
| Start Date | 2019-06-20 |
| Est. Completion | 2021-09-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03982979
The ClinicalTrials.gov registry entry for NCT03982979 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 295 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HM3 LVAS is the first listed.
NCT03982979 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03982979 about?
NCT03982979 is a clinical study titled "MOMENTUM 3 Pivotal Cohort Extended Follow-up PAS". The study will be a prospective, multi-center, non-blinded, controlled study, intended to evaluate the extended use of the HM3 LVAS compared to the HMII LVAS in those patients that are ongoing at the 2-year follow-up in the MOMENTUM 3 IDE trial. A total of 1028 subjects were enrolled in the MOMENTUM...
What is the current status of trial NCT03982979?
This trial is currently completed. The enrollment target is 295 participants. The study started on 2019-06-20. Estimated completion is 2021-09-08.
What interventions are being tested in trial NCT03982979?
The interventions under investigation include: HM3 LVAS (DEVICE).
Who is sponsoring clinical trial NCT03982979?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.